250 related articles for article (PubMed ID: 32460887)
21. De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome.
la Martire G; Robin C; Oubaya N; Lepeule R; Beckerich F; Leclerc M; Barhoumi W; Toma A; Pautas C; Maury S; Akrout W; Cordonnier-Jourdin C; Fihman V; Venditti M; Cordonnier C
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1931-1940. PubMed ID: 30051357
[TBL] [Abstract][Full Text] [Related]
22. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
23. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
24. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
25. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
26. Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy.
Sathya Kumar AM; George MM; Bhanuprasad K; John GM; Korula A; Abraham A; Mathews V; Kulkarni UP; Shankar C; Premkumar PS; Chacko B; Subramani K; Varghese GM; Balaji V; George B
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):12. PubMed ID: 36793051
[TBL] [Abstract][Full Text] [Related]
27. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
[TBL] [Abstract][Full Text] [Related]
28. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
29. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial stewardship in high-risk febrile neutropenia patients.
Contejean A; Abbara S; Chentouh R; Alviset S; Grignano E; Gastli N; Casetta A; Willems L; Canouï E; Charlier C; Pène F; Charpentier J; Reboul-Marty J; Batista R; Bouscary D; Kernéis S
Antimicrob Resist Infect Control; 2022 Mar; 11(1):52. PubMed ID: 35346373
[TBL] [Abstract][Full Text] [Related]
31. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.
Carratalà J; Niubó J; Fernández-Sevilla A; Juvé E; Castellsagué X; Berlanga J; Liñares J; Gudiol F
Antimicrob Agents Chemother; 1999 Sep; 43(9):2200-4. PubMed ID: 10471564
[TBL] [Abstract][Full Text] [Related]
33. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
34. Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome.
van de Peppel RJ; Dekkers OM; von dem Borne PA; de Boer MG
Med Mycol; 2014 Oct; 52(7):699-705. PubMed ID: 25049037
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
[TBL] [Abstract][Full Text] [Related]
36. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
37. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
38. Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
Platzbecker U; Middeke JM; Sockel K; Herbst R; Wolf D; Baldus CD; Oelschlägel U; Mütherig A; Fransecky L; Noppeney R; Bug G; Götze KS; Krämer A; Bochtler T; Stelljes M; Groth C; Schubert A; Mende M; Stölzel F; Borkmann C; Kubasch AS; von Bonin M; Serve H; Hänel M; Dührsen U; Schetelig J; Röllig C; Kramer M; Ehninger G; Bornhäuser M; Thiede C
Lancet Oncol; 2018 Dec; 19(12):1668-1679. PubMed ID: 30442503
[TBL] [Abstract][Full Text] [Related]
39. Comparison of sulbactam-cefoperazone with carbapenems as empirical monotherapy for febrile neutropenic children with lymphoma and solid tumors.
Demir HA; Kutluk T; Ceyhan M; Yağcı-Küpeli B; Akyüz C; Cengiz B; Varan A; Kara A; Yalçın B; Seçmeer G; Büyükpamukçu M
Pediatr Hematol Oncol; 2011 May; 28(4):299-310. PubMed ID: 21413829
[TBL] [Abstract][Full Text] [Related]
40. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia.
Ford CD; Lopansri BK; Haydoura S; Snow G; Dascomb KK; Asch J; Bo Petersen F; Burke JP
Infect Control Hosp Epidemiol; 2015 Jan; 36(1):47-53. PubMed ID: 25627761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
